Dr. Robert Kellar is an Associate Professor at Northern Arizona University in the Center for Materials Interfaces in Research Applications (¡MIRA!), Biological Sciences, and Mechanical Engineering. During his academic career, Dr. Kellar has secured over $12.3M in research funding. He serves as the CEO for Development Engineering Sciences, Chief Science Officer for Axolotl Biologix, and the Chief Technology officer for NEXT Life Sciences. Dr. Kellar has over 21 years of experience in the development and regulatory approval of medical devices, pharmaceuticals, and biologics, including cell-based products and regenerative medicine and tissue engineered technology. He has over 154 scientific abstracts, 42 peer-reviewed publications, and 7 issued US patents, and has raised over $100M in capital to support various start-ups. He received his PhD from the University of Arizona in 2001.

Dr. Kellar currently serves on the Board for Leonhardt Ventures, the Clinical Advisory Board for Aesthetics Biomedical, and the Advisory Board for the California Stock Exchange. Dr. Kellar has helped to co-found a number of companies including Development Engineering Sciences, a biomedical consulting firm; Protein Genomics, a protein polymer company; Flagship Biosciences, a digital pathology company; Elevated Manufacturing, a contract manufacturer; KMP Global, a technology holding company.

Dr. Kellar’s previous roles include: Past-President of the Surfaces in Biomaterials Foundation, VP of Research and Development at Histogen, Inc. in San Diego, CA, Product Specialist at W.L. Gore and Associates in Flagstaff, AZ, and Lead Scientist and Project Manager at Advanced Tissue Sciences, Inc. in La Jolla, CA.